Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233)

John Anderson,Ghandi Al-Ali,Manfred P. Wirth,Joan Benejam Gual,Francisco Gómez Veiga,Enrico Colli,Egbert van der Meulen,Bo-Eric Persson

Degarelix versus Goserelin (+ Antiandrogen Flare Protection) in the Relief of Lower Urinary Tract Symptoms Secondary to Prostate Cancer: Results from a Phase IIIb Study (NCT00831233)

2013

John Anderson
Ghandi Al-Ali
Manfred P. Wirth
Joan Benejam Gual
Francisco Gómez Veiga
Enrico Colli
Egbert van der Meulen
Bo-Eric Persson

Introduction: No studies to date have assessed the efficacy/tolerability of degarelix in the relief of lower urinary tract symptoms (LUTS) secondary to prostate c

Keywords:

Prostate cancer
Antiandrogen
Urology
Degarelix
Prostate
Goserelin
Tolerability
Medicine
Lower urinary tract symptoms

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations